P. Gorombei

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

G. Mufti, V. Vanneaux, L. Sarda-Mantel, 2016, Journal of Hematology & Oncology.

BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.

D. Felsher, M. Konopleva, M. Andreeff, 2013, Blood.

Niclas mouse model of AML by targeting primitive LSK and progenitor cells BCL-2 inhibition with ABT-737 prolongs survival in an NRAS / BCL-2

D. Felsher, M. Konopleva, M. Andreeff, 2013 .

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice

V. Mathews, P. Fenaux, L. Adès, 2015, Blood Cancer Journal.

The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1

A. Falini, R. Galli, A. Molinari, 2018, Cell Death & Differentiation.

DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies

V. Mathews, P. Fenaux, N. Tekin, 2015, Oncotarget.

The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1

A. Falini, R. Galli, A. Molinari, 2018, Cell Death & Differentiation.

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

P. Merlet, M. Konopleva, M. Andreeff, 2021, International journal of molecular sciences.